跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,378 条关于
“PI3K kinase”
全部
4,378
临床试验
1,997
药物
517
机构
18
资讯
1,846
去年
NGS and Targeted Therapies Improve Survival in HR+/HER2- Breast Cancer
去年
PADMA Trial: Palbociclib Plus Endocrine Therapy Significantly Extends Time to Treatment Failure in Advanced Breast Cancer
去年
Adlai Nortye's Buparlisib Poised to Potentially Be First PI3K Inhibitor for Head and Neck Cancer
去年
Adlai Nortye's AN2025 Shows Promise in Head and Neck Cancer Treatment
去年
Secura Bio Initiates Phase 3 TERZO Trial of COPIKTRA for Rare T-Cell Lymphoma
去年
Palvella Therapeutics Doses First Patient in Phase 3 Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations
去年
Capivasertib Causes Distinctive Glucose Spikes in Breast Cancer Patient, Prompting Japanese Safety Warning
9个月前
Secura Bio Reports Sustained Efficacy of Duvelisib in Heavily Pretreated Peripheral T-Cell Lymphoma Patients
去年
Bimiralisib Gel Shows Promising Results in Phase 2 Trial for Actinic Keratosis
去年
Paxalisib, TTFields, and Proton Irradiation Show Promise in Neuro-oncology
第 1 页,共 185 页
上一页
下一页